Clinical Endpoint Bioequivalence Study for Fluticasone Propionate and Salmeterol Xinafoate
Clinical trial NCT02649478 · COMPLETED
Trial details
- NCT number
- NCT02649478
- Sponsor
- Roxane Laboratories
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2014-08-01
- Primary completion
- 2015-11-01
- Enrollment
- 1430
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.